BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2015
View Archived Issues
Preliminary data reported from phase I/IIa study of third-generation CAR T cells targeting CD19
Read More
SVN-2B peptide vaccination shows promise for gastrointestinal cancer
Read More
Phase I clinical trial shows promising results for TIL 1383I transduced T cells
Read More
JCR and Sumitomo Dainippon Pharma enter feasibility agreement in psychiatry and neurology
Read More
Avalon Ventures and GSK launch new companies Adrenergics, CadheRx and Calporta
Read More
Queensland Emory Drug Discovery Initiative announced
Read More
Once-weekly LAPSInsulin Combo shows better glycemic control, reduced side effects
Read More
Eppin Pharma receives NIH grant to develop non-hormonal male contraceptive
Read More
FDA approves Zomig Nasal Spray for patients aged 12-17 years
Read More
Novartis to develop inhaled indacaterol/glycopyrronium bromide/mometasone furoate
Read More
Teva releases topline data from pivotal study of SD-809 for tardive dyskinesia
Read More
FDA clears IND for U.S. study of GTL-001 HPV therapeutic vaccine candidate
Read More
Novel gene therapy shows promising results in mouse models of Friedreich's ataxia
Read More
Fagron licenses U.S. rights to OMS-103 from Omeros
Read More
OncoSec Medical starts phase II study of ImmunoPulse in HNSCC
Read More
AveXis licenses rights to AskBio's AAV Duplex vector technology for use in SMA gene therapy
Read More
Admune Therapeutics starts phase I trial of hetIL-15 in metastatic cancers
Read More
Aimmune Therapeutics receives FDA breakthrough therapy designation for AR-101
Read More
Roche and Genentech introduce BTK inhibitors
Read More
Lead Pharma patents RORgamma modulators
Read More
Sichuan Haisco discloses FXa inhibitors
Read More
Jiangsu Aosaikang discloses EGFR inhibitors
Read More
Beijing JenKem presents EGFR inhibitors for AD
Read More
World Sickle Cell Day: LentiGlobin gene therapy continues to impress in clinical study
Read More
Allergan to acquire Kythera Biopharmaceuticals
Read More
Tribute Pharmaceuticals acquires Medical Futures
Read More
Akashi Therapeutics reports data on HT-100 in patients with DMD
Read More